metricas
covid
Clinics Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome ...
Journal Information

Statistics

Follow this link to access the full text of the article

RAPID COMMUNICATION
Assessing the benefits of rosiglitazone in women with polycystic ovary syndrome through its effects on insulin-like growth factor 1, insulin-like growth factor-binding protein-3 and insulin resistance: a pilot study
José Gomes BatistaI,,II,
Corresponding author
jsoares415@hotmail.com

Tel.: 55 11 5081-3865
, José Maria Soares JrI,,III, Carla Cristina MaganhinI, Ricardo Santos SimõesIII, Geraldez TomazII, Edmund Chada BaracatI,III
I Federal University of São Paulo (UNIFESP), Gynecology Department, São Paulo/SP, Brazil
II Federal University of Paraíba (UFPB), Obstetrics and Gynecology Department, João Pessoa/PB, Brazil
III Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Gynecology Department, São Paulo/SP, Brazil
Read
1068
Times
was read the article
377
Total PDF
691
Total HTML
Share statistics
Article information
ISSN: 18075932
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 27 10 37
2025 11 82 25 107
2025 10 54 11 65
2025 9 38 11 49
2025 8 32 6 38
2025 7 43 10 53
2025 6 22 0 22
2025 5 17 2 19
2025 4 16 2 18
2025 3 26 7 33
2025 2 10 1 11
2025 1 15 6 21
2024 12 11 1 12
2024 11 36 17 53
2024 10 17 20 37
2024 9 21 22 43
2024 8 36 27 63
2024 7 14 19 33
2024 6 20 8 28
2024 5 14 15 29
2024 4 14 20 34
2024 3 15 14 29
2024 2 9 10 19
2024 1 12 8 20
2023 12 8 15 23
2023 11 10 16 26
2023 10 11 21 32
2023 9 12 21 33
2023 8 9 8 17
2023 7 6 10 16
2023 6 7 1 8
2023 5 2 0 2
2023 4 3 1 4
2023 3 7 0 7
2023 2 9 11 20
2023 1 3 0 3
2022 12 3 1 4
Show all

Follow this link to access the full text of the article